KCT0008183招募中未知
Effectiveness verification of Mirtazapine in Patients with Acute Anxiety
Chung-Ang Univerisity Hospital0 个研究点目标入组 52 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 52
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 18(Year) 至 65(Year)（—）
- 性别
- All
入选标准
- •? The age of 18 to 65
- •? A person diagnosed as a major depressive disorder without psychotic features. by Structured Clinical Interview for DSM-5 (SCID-5)
- •? BAI scale score is 16 or higher (with moderate or higher anxiety symptoms)
- •? Those who have no history of using Mirtazapine in the last two months based on the initial evaluation point
- •? Those who have been administering antidepressants (SSRI, SNRI and NDRI) at stable doses for more than 1 month
排除标准
- •? A person who has been diagnosed other psychiatric diagnosis by SCID-5-CV in the past
- •? Those who currently have severe medical conditions (cancer, heart failure, kidney failure, liver disease, lung disease, thyroid disease and acute inflammatory conditions)
- •? A person who has a history of past or present dependence on substances or misuse
- •? A person with a history of epilepsy, head trauma, and organic mental illness
研究者
相似试验
招募中
1 期
The effectiveness of mirtazapine in reducing dependence and the temptation to consume amphetamine and methamphetamine in patientsIRCT20230606058397N1Ahvaz University of Medical Sciences84
尚未招募
3 期
Comparison of shivering in drugs of Mirtazapine , Dexamethasone and Tramadol after spinal anaesthesiaCTRI/2023/12/060608SRINIVASAN T
招募中
3 期
Effect of Mirtazapine on the quality of life of the breast cancer patientsIRCT20210425051075N1Sabzevar University of Medical Sciences110
已完成
3 期
Effect of topical mirtazapine on eczemaAtopic dermatitis.Other atopic dermatitisIRCT2015071722965N3Vice chancellor for research, Hamadan University of Medical Sciences120
已完成
不适用
Efficacy of add-on mirtazapine on clinical and neuropsychologic parameters in schizophrenic patients treated with conventional antipsychotics: a double-blind, placebo-controlled trial with an open-label extension phaseSchizophreniaISRCTN00721331Stanley Medical Research Institute (USA)40